fasidotrilat   Click here for help

GtoPdb Ligand ID: 6502

Compound class: Synthetic organic
Comment: Active drug formed from the metabolism of prodrug fasidotril. Fasidotrilat has not been assigned an INN itself.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 123.66
Molecular weight 311.08
XLogP 1.35
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES SCC(C(=O)NC(C(=O)O)C)Cc1ccc2c(c1)OCO2
Isomeric SMILES SC[C@H](C(=O)N[C@H](C(=O)O)C)Cc1ccc2c(c1)OCO2
InChI InChI=1S/C14H17NO5S/c1-8(14(17)18)15-13(16)10(6-21)4-9-2-3-11-12(5-9)20-7-19-11/h2-3,5,8,10,21H,4,6-7H2,1H3,(H,15,16)(H,17,18)/t8-,10+/m0/s1
InChI Key TXSINLUUGRGAJO-WCBMZHEXSA-N
References
1. Abbenante G, Fairlie DP. (2005)
Protease inhibitors in the clinic.
Med Chem, 1 (1): 71-104. [PMID:16789888]
2. Tsantili-Kakoulidou A, Nicolaou I, Vrakas D, Demopoulos VJ. (2005)
Modelling of aldose reductase inhibitory activity of pyrrol-1-yl-acetic acid derivatives by means of multivariate statistics.
Med Chem, 1 (4): 321-6. [PMID:16789889]